A Prescription for Pharma: How DCT Technology
Partnerships Deliver Better Patient Journeys,
Diversity, and Adherence

Diversity in clinical research is a growing concern for regulators and sponsors. The challenge is: how can sponsors recruit diverse patient populations while the industry grapples with widespread recruitment and retention challenges? 

By bringing trials to the desired cohorts of patients, sponsors can break down the barriers that impede target populations from participating in research and provide patient-centered journeys that keep patients engaged every step of the way.

During this live 30-minute discussion and Q&A, experts from THREAD, Almac, and AARDEX Group will discuss:

• Pathways to improving population diversity in clinical research.
• How Almac, Thread, and AARDEX Group’s patient-first approach to study design makes for studies that patients want to participate in.
• Optimizing the patient journey and improving medication adherence in DCTs.

Save your spot now for this free-to-attend virtual event now!